Liu_2020_Chem.Pharm.Bull.(Tokyo)_68_161

Reference

Title : Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Abeta Aggregation Activity through Molecular Docking-Based Virtual Screening - Liu_2020_Chem.Pharm.Bull.(Tokyo)_68_161
Author(s) : Liu G , Jiao Y , Lin Y , Hao H , Dou Y , Yang J , Jiang CS , Chang P
Ref : Chem Pharm Bull (Tokyo) , 68 :161 , 2020
Abstract :

Discovery of novel multifunctional inhibitors targeting acetylcholinesterase (AChE) has becoming a hot spot in anti-Alzheimer's disease (AD) drug development. In the present study, four potent small molecule inhibitors (A01, A02, A03 and A04) of AChE with new chemical scaffold were identified. Inhibitor A03 displayed the most potent inhibition activity on AChE at enzymatic level with IC50 value of 180 nM, and high selectivity towards AChE over butyrylcholinesterase (BChE) by more than 100-fold. The binding modes of compounds A01-A04 were carefully analyzed by molecular docking and molecular dynamics (MD) simulation to provide informative clues for further structure modification. Finally, the anti-amyloid beta (Abeta) aggregation and neuroprotective activity were also well investigated. Our findings highlighted the therapeutic promise of AChE inhibitors A01-A04 for AD treatment.

PubMedSearch : Liu_2020_Chem.Pharm.Bull.(Tokyo)_68_161
PubMedID: 31813907

Related information

Citations formats

Liu G, Jiao Y, Lin Y, Hao H, Dou Y, Yang J, Jiang CS, Chang P (2020)
Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Abeta Aggregation Activity through Molecular Docking-Based Virtual Screening
Chem Pharm Bull (Tokyo) 68 :161

Liu G, Jiao Y, Lin Y, Hao H, Dou Y, Yang J, Jiang CS, Chang P (2020)
Chem Pharm Bull (Tokyo) 68 :161